Primary care for you and your family, close to home.
People with colon cancer are supported with collaborative, personalized care at Wellstar.
At Wellstar, people with colon cancer have highly coordinated and collaborative care—close to home. Our multidisciplinary team of gastrointestinal (GI) cancer experts offers the most advanced diagnostics, treatments and clinical trials. People cared for here have access to the largest volume genetics program in the state.
Our GI cancer specialists stay on the forefront of screening, diagnosis and evidence-based treatment for colon cancer. Patients benefit from our multidisciplinary GI tumor board, where physicians meet to diagnose and design treatment plans together. Wellstar is the first health system in Georgia that is a member of the Mayo Clinic Care Network. Through this relationship, our GI cancer experts have a direct connection to Mayo Clinic specialists and can request electronic consultations and second opinions at no additional cost to the patient.
Wellstar is accredited by the Commission on Cancer (CoC), a program by the American College of Surgeons (ACS) and is the recipient of the organization’s Outstanding Achievement Award, the highest honor awarded to a cancer program in the United States.
Colon cancer that is found in its earliest stages is highly curable, underscoring the importance of regular screening. Screening should happen at regular intervals, before symptoms are ever experienced.
People have options for colorectal cancer screening and it's important to know that some screening tests have more benefits than others. Our cancer experts say the most important thing for your health is to get screened, whichever test you choose. Talk to your primary care physician about the best time to begin screening and which test is right for you.
Our team considers the colonoscopy the gold standard because it offers the ability to remove pre-cancerous polyps, completely preventing colon cancer.
Other screening tests are available such as the Fecal Immunochemical Test (FIT) and the stool DNA test. The FIT test detects blood in the stool. The stool DNA test looks for genetic mutations in the stool specimen. These tests have varying detection rates for identifying colon cancer but are less accurate at finding pre-cancerous colon polyps. A positive test will require a colonoscopy.
Learn more about colorectal cancer screenings at Wellstar, including when screening is recommended and the closest location to you.
Approximately 10% of all cancers of the gastrointestinal (GI) tract are caused by a hereditary cancer syndrome. Home to the largest volume cancer genetics program in the state of Georgia, Wellstar identifies hereditary cancer syndromes that increase the risk of having colon cancer or other types of hereditary cancer. When appropriate, preventative screening and surgical options may help reduce the likelihood of future cancers within a family.
Every patient who has surgery for colon cancer at Wellstar is automatically screened for hereditary cancer syndromes, which include testing for Lynch syndrome—the most common.
Further genetic counseling is offered to:
Your board-certified genetic counselor will take a detailed family and medical history and if it is appropriate, will discuss genetic testing options. Genetic counseling and testing is typically covered by insurance if it is considered medically necessary.
Learn more about the Wellstar Genetic Risk Assessment program.
Our patients have access to the latest clinical trials for colon cancer, participating in groundbreaking local, regional and national studies. Wellstar’s clinical research team has a strong track record of choosing impactful studies to participate in.
For example, Wellstar was one of the first cancer treatment centers in the country to offer immunotherapy for colon cancer. This study—known as the KEYNOTE-177 trial from Merck—led to the first approval of immunotherapy in colon cancer by the FDA in 2020, specifically for metastatic colon cancer with DNA mismatch repair deficiency. Wellstar patients had access to this treatment four years before FDA approval.
Colon cancer is typically diagnosed when a colonoscopy finds cancer inside of a polyp, or as a mass in the colon when:
Symptoms of colon cancer can include:
At Wellstar, patients who are found to have cancer, superficial cancer or pre-cancerous polyps follow an evidence-based treatment path to have the best outcomes:
Read more about treatment for colon cancer by clicking on the tab to your left.
To give patients a chance at the best outcomes, our colon cancer specialists work closely in a multidisciplinary team to provide evidence-based, high-quality colon cancer care at Wellstar.
Our GI cancer experts meet regularly to collaborate and stay up-to-date on the National Comprehensive Cancer Network (NCCN) Guidelines. Some treatments may be more effective than others based on a variety of information, including a patient’s age, personal and family history as well as the stage of their cancer and other data found in their pathology report.
When a tumor is localized to the colon and hasn’t spread to other parts of the body, a patient typically benefits from having a colon resection surgery first, which may be followed by chemotherapy.
When a patient has a colon resection, the part of the colon with cancer is removed and the healthy ends are rejoined. This procedure can be performed as an open or minimally-invasive surgery. Wellstar surgeons who perform minimally-invasive colon cancer surgery have a high volume of experience in both laparoscopic and robotic-assisted colon resections. Our surgeons who perform robotic-assisted colon resections have access to the latest state-of-the-art da Vinci surgical systems.
After the surgery, the entire tumor is evaluated by a skilled Wellstar pathologist who runs molecular tests, protein studies and sometimes, next generation sequence studies. These tests provide detailed information to help optimize each patient’s personalized treatment plan. The pathology report may reveal information that supports additional therapy, which may lower the risk of the cancer returning.
For patients with specific biomarker testing results, targeted therapy may be the most beneficial treatment.
In some cases, adjuvant therapy is administered for three to six months as chemotherapy. This traditional cancer drug treats the whole system, and is proven to improve outcomes in colon cancer care.
If a patient is found to have metastatic colon cancer—cancer that has spread to other areas of the body—a different treatment path can be more effective. Treatment options can include chemotherapy, targeted therapies like immunotherapy, radiation or surgery.
After a patient completes the full course of treatment, they can expect to continue to see their gastroenterologist, who helps manage their surveillance after surgery and continues to monitor for cancer in the future.
We recognize that people with colon cancer need support beyond medical treatment. At Wellstar, you’ll be surrounded with a compassionate team of cancer surgeons, medical oncologists and cancer-specific support team members. Our patients experience a highly personalized level of guidance and support by GI cancer-specific nurse navigators, as well as oncology-specific dietitians, social workers, psychologists, psychiatrists and counselors.
Many patients with colon cancer experience painful blockages and distress due to the colon cancer itself as well as pain and fatigue as result of treatment. Highly specialized palliative care physicians work with patients to manage symptoms and side effects. The goal of these specialists is to improve your quality of life. A variety of symptom-controlling techniques may be used and managed, including drugs, diet and nutrition as well as fluid and electrolyte balance.
Our patients can also work with oncology-specific psychological psycho-oncology team members such as a psychologist, psychiatrist or counselor.
Your nurse navigator can also connect you with our cancer support groups, which can offer a safe place to share what you’re going through and help you gain confidence to keep moving forward.